2004 highlights from: 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, Louisiana, June 2004.
Nancy
N
Price
G Kesava
GK
Reddy
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000208:ethnology / Q000628:therapy*; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D005006:Ethnicity; D006801:Humans; D008175:Lung Neoplasms / Q000208:ethnology / Q000628:therapy*; D008875:Middle Aged; D011799:Quinazolines / Q000494:pharmacology / Q000627:therapeutic use; D012955:Societies, Medical; D014481:United States / Q000453:epidemiology
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors